An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai
Currently, there is no treatment that slows the progression of the disease, which is the leading cause of vision loss in people over 65.
“This is the first study to show preservation of vision after a single injection of adult-derived human cells into a rat model with age-related macular degeneration,” said Shaomei Wang, MD, PhD, lead author of the study published in the journal STEM CELLS and a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute.
The stem cell injection resulted in 130 days of preserved vision in laboratory rats, which roughly equates to 16 years in humans.
Age-related macular degeneration affects upward of 15 million Americans. It occurs when the small central portion of the retina, known as the macula, deteriorates. The retina is the light-sensing nerve tissue at the back of the eye. Macular degeneration may also be caused by environmental factors, aging and a genetic predisposition.
When animal models with macular degeneration were injected with induced neural progenitor stem cells, which derive from the more commonly known induced pluripotent stem cells, healthy cells began to migrate around the retina and formed a protective layer. This protective layer prevented ongoing degeneration of the vital retinal cells responsible for vision.
Cedars-Sinai researchers in the Induced Pluripotent Stem Cell (iPSC) Core, directed by Dhruv Sareen, PhD, with support from the David and Janet Polak Foundation Stem Cell Core Laboratory, first converted adult human skin cells into powerful induced pluripotent stem cells (iPSC), which can be expanded indefinitely and then made into any cell of the human body. In this study, these induced pluripotent stem cells were then directed toward a neural progenitor cell fate, known as induced neural progenitor stem cells, or iNPCs.
“These induced neural progenitor stem cells are a novel source of adult-derived cells which should have powerful effects on slowing down vision loss associated with macular degeneration,” said Clive Svendsen, PhD, director of the Board of Governors Regenerative Medicine Institute and contributing author to the study. “Though additional pre-clinical data is needed, our institute is close to a time when we can offer adult stem cells as a promising source for personalized therapies for this and other human diseases.”
Read more: Stem Cell Injection May Soon Reverse Vision Loss Caused By Age-Related Macular Degeneration
The Latest on: Age-Related Macular Degeneration
[google_news title=”” keyword=”Age-Related Macular Degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-Related Macular Degeneration
- IVERIC bio gets grant for carbocyclic prolinamide derivatives for treating age-related macular degenerationon March 29, 2024 at 4:38 am
Discover IVERIC bio's groundbreaking patent for carbocyclic prolinamide derivatives, a game-changer in treating eye diseases like macular degeneration. Explore the potential of HTRA1 inhibitors for ...
- REGENXBIO Sees Positive Results For Macular Degeneration Therapyon March 28, 2024 at 10:10 am
By Karen Roman REGENXBIO Inc. (Nasdaq: RGNX), a clinical-stage biotechnology company, said its subretinal treatment of age-related macular degeneration showed improved vision in patients. Two years of ...
- Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trialon March 26, 2024 at 8:01 am
The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration ...
- How Macular Degeneration Changes What You Seeon March 22, 2024 at 10:46 am
Macular degeneration, depending on the type, distorts vision by making people see dots and blurriness. Learn examples of dry and wet AMD vision changes.
- Age-Related Macular Degeneration: Do Americans “Get” It?on March 19, 2024 at 5:00 pm
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rates of age-related macular degeneration (AMD), a leading cause of blindness in adults in the U.S., continue to grow ...
- Neovascular Age-Related Macular Degenerationon March 17, 2024 at 5:00 pm
Choroidal neovascularization is the primary cause of visual loss in patients with age-related macular degeneration. Current treatments, proven to offer a benefit for these patients through ...
- Can Macular Degeneration Cause Visual Hallucinations?on March 15, 2024 at 7:30 pm
Macular degeneration can lead to vision loss. In turn, people with vision loss may experience visual hallucinations (seeing things that aren't there). This is known as Charles Bonnet syndrome (CBS).
- Dry Age-Related Macular Degeneration Size, Share | Growth Report 2031on March 15, 2024 at 2:04 am
Age-related macular degeneration (AMD) disease causes the small central retinal macula of the eye to deteriorate. A crucial retina component is the ...
- What is dry age-related macular degeneration (AMD)?on March 3, 2024 at 4:00 pm
Age-related macular degeneration (AMD) is a disease that causes progressive vision loss. Dry AMD is a subtype, and it typically progresses more slowly than wet AMD. The cause of dry AMD is damage ...
- Complement C3 Variant and the Risk of Age-Related Macular Degenerationon February 28, 2024 at 3:59 pm
Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors. Complement activation ...
via Bing News